T he term ''syndrome de déséquilibration'' was probably first employed by Alajouanine et al 1 in a case report in the 1940s and subsequently adopted as ''Dysequilibrium syndrome'' by Hagberg et al 2 and Sanner 3 to classify what we now know as a spectrum of genetically heterogeneous conditions that combine autosomal recessive, nonprogressive cerebellar ataxia with mental retardation. Dysequilibrium syndrome was described in the endogamous North American Hutterite population in the 1980s 4, 5 and further characterized as a nonprogressive syndrome of moderate-to-profound mental retardation, delayed ambulation, and predominantly truncal ataxia in a review of 12 patients in 2005. 6 Additional features included strabismus and pes planus in the majority of patients and seizures in 40% and short stature in 15% of patients. Magnetic resonance imaging (MRI) demonstrated inferior cerebellar hypoplasia and mild cortical gyral simplification. 6 An identity-by-descent mapping approach localized the gene for dysequilibrium syndrome in the Hutterites to 9p24 and a 199 kb homozygous deletion encompassing the entire very low-density lipoprotein receptor (VLDLR) coding region, including upstream promoter and downstream sequences, was present in all affected individuals. 7 VLDLR is a member of the lowdensity lipoprotein receptor (LDLR) gene family 8 and part of the Reelin signalling pathway, 9 which guides neuroblast migration in the cerebral cortex and cerebellum (reviewed in reference 10). Very recently, 3 different and independent loss-of-function mutations in VLDLR have been reported in families from Iran 11 and Turkey, 12, 13 confirming the central role of VLDLR in some forms of dysequilibrium syndrome. This report describes the first compound heterozygous patient who carries 2 novel mutations in VLDLR and reviews this emerging clinically and molecularly well-defined syndrome.
Case Report
The patient is a 26-month-old girl seen for neurogenetic consultation at 18 months of age because of an abnormal MRI and developmental delay. She is one of a dizygotic twin pregnancy complicated by maternal diabetes, well controlled with insulin therapy. Delivery at 36 weeks' gestation was uneventful. Her birth weight was 5 pounds 6 ounces, and her Apgar scores were normal. Family history is unremarkable. Her twin sister and older sister are normal. The parents are nonconsanguineous; the mother of Irish-German descent and the father of Scottish-German descent.
Developmental concerns were raised at 4 months of age when hypotonia and motor delay were noted. Gross motor milestones include rolling at 13 months of age, rolling in both directions at 15 months of age, and using rolling to reach a point in the room at 17 months of age. She was able to maintain a sitting position when propped up for about 30 seconds and stand in a standing frame with locked knees at 18 months of age. By 26 months of age, she was able to sit without support for prolonged periods, get to sitting, commando crawl, and pull to a kneeling position. She developed a pincer grasp at 17 months and could bang toys together at 18 months of age. At 26 months of age, expressive and receptive language is delayed; she babbles and understands a few commands. She is now beginning to wave ''bye-bye.'' At 26 months, she was assessed and fine motor and social skills were at approximately a 12-month-old level, gross motor skills were scattered between 7 and 10 months, and language skills were between 6 and 9 months, consistent with global developmental delay with more significant impairment in gross motor and language skills.
Examination at 18 and 26 months revealed a wellappearing small child. Her weight at 26 months was 9.6 kg (less than fifth percentile), height was 76 cm (less than fifth percentile), and head circumference was 45.5 cm (fifth to tenth percentile). She had full extraocular movements, normal reactive pupils, normal facial strength, and her tongue was midline without fasiculations. She had some lower facial hypotonia with drooling. Her saccades were hypometric and smooth pursuit was abnormal. Muscle tone was overall decreased. Deep tendon reflexes were symmetric and brisk, plantar responses were flexor, and there was no clonus. Her grasp was immature. Truncal unsteadiness was evident and she had dysmetria with reaching.
Magnetic resonance imaging of the brain revealed hypoplasia of the inferior portion of the cerebellar vermis as well as the hemispheres (Figure 1 ). The brainstem was small, particularly the pons. The sulcation pattern was simplified with minimally thickened but uniform cortex without a clear anteroposterior gradient. The MRI findings were identical to those seen in Hutterite patients with a homozygous VLDLR deletion.
Molecular Methods
Sequence analysis was performed following polymerase chain reaction (PCR) amplification of each of the 19 exons of the VLDLR gene from genomic DNA from the patient and a control. Primers (sequences available upon request) were located within flanking introns allowing for the detection of splicing mutations. Patient sequences were compared to control sequences and to the Genbank sequence (accession NT_008413.17) using Mutation Surveyor software (SoftGenetics, State College, Pennsylvania). Sequence analysis of VLDLR exon 11 and 12 was performed in DNA from the patient's parents to identify phase of the variants. Analysis of exon 11 in 100 individuals was performed to detect the VLDLR p.D521H variant. 
Results
Sequencing of VLDLR revealed a paternal missense mutation (c.1561G>C, p.D521H) in exon 11 and a maternal frameshift mutation (c.1711_1712dupT, p.Y571LfsX7) in exon 12 of the VLDLR gene in the affected patient ( Figure 2A ). The frameshift mutation alters codons 571 to 576 before introducing a premature stop codon, resulting in the partial loss of the YWTD domain and loss of the o-linked sugar, transmembrane, and cytoplasmic domains. 14 The p.D521H mutation is predicted to be disease-causing. Sequence analysis in 100 control individuals did not detect p.D521H. It is located within a highly conserved region in the extracellular b-propeller domain 15 ; this codon is completely conserved between VLDLR and other family members (including LDLR, apolipoprotein E receptor-2 (APOER2), low-density lipoprotein related protein 1 [LRP1], LRP1B, LRP2, and LRP4 16 ; Figure 2B ). In the LDLR, sequence alterations in the equivalent position D482 and the neighboring amino acid W483 invariably result in familial hypercholesterolemia. 17, 18 The functional loss associated with mutations at these positions is likely a result of misfolding and impaired export of the receptors to the cell surface. 19 
Discussion
Dysequilibrium syndrome is a descriptive term that encompasses a spectrum of genetically heterogeneous clinical conditions that combine autosomal recessive, nonprogressive cerebellar ataxia with mental retardation. VLDLR-associated cerebellar hypoplasia is emerging as a clinically and molecularly well-defined subgroup of dysequilibrium syndrome. Including this report, 6 mutations in VLDLR have now been identified in 5 families (Table 1 ; Figure 2C ). The phenotype is characterized by moderateto-profound mental retardation, delayed ambulation, truncal and peripheral ataxia, dysarthric speech, strabismus, and occasional seizures. Neuroanatomically, the effect of the different mutations is indistinguishable and the characteristic brain malformation is distinct and easily recognizable. The MRI findings include hypoplasia of the inferior portion of the cerebellar vermis and hemispheres, simplified gyration of the cerebral hemispheres with minimally thickened but uniform cortex without a clear anteroposterior gradient, and small brainstem, particularly the pons.
Patients with this form of dysequilibrium syndrome typically learn to walk very late (after the age of 6 years) or else never walk at all. Individuals with dysequilibrium syndrome who ambulate independently demonstrate a wide-based ataxic gait, which has been well documented in the Hutterite population. 6 By contrast, the families reported from Turkey 12,13 present with a high incidence of quadrupedal locomotion. Ozcelik et al 12 proposed that the presence of quadrupedal locomotion in these individuals is evidence for ''human devolution'' or ''reverse evolution.'' However, this is not supported by clinical, evolutionary, or molecular evidence; quadrupedal locomotion is more readily and easily explained as a behavioral adaptation to the severe orthostatic instability caused by the profound cerebellar hypoplasia. The emergence of this clinically spectacular trait and its perpetuation into adulthood is most likely promoted by environmental conditions during adolescence, such as uneven surfaces in rural areas and lack of useful adaptive devices, which would favor a habitual lowering of the body's center of gravity to avoid injury. 13, 20 Very low-density lipoprotein receptor is part of the Reelin signaling pathway, 9 which guides neuroblast migration in the developing cerebral cortex and cerebellum (reviewed in reference 10). In an evolutionarily highly conserved pathway, Reelin (RELN) engages 2 lipoprotein receptors, VLDLR and APOER2, which results in phosphorylation of the intracellular adaptor protein disabled-1 (DAB1). 21, 22 This phosphorylation step is the ''master switch'' that activates an intracellular signalling cascade that allows neuroblasts to receive the critical positional cues required to form ordered cortical layers. Loss-offunction mutations in the human RELN gene are the cause of an autosomal recessive syndrome consisting of severe cerebellar hypoplasia combined with lissencephaly. 23 Human neurodevelopmental defects in DAB1 or APOER2 have so far not been found. Turkmen and colleagues 24 have identified a 7-Mb minimal region between markers D17S1866 and D17S960 on chromosome 17 as the likely location for another autosomal recessive mutation that causes a similar form of cerebellar hypoplasia and a high incidence of preferred quadrupedal locomotion in consanguineous Turkish pedigrees. We have identified a plausible candidate gene in this region, CRK, a member of a family of intracellular adapter proteins that participate in the intracellular propagation of Reelin signalling downstream of disabled-1. 25 Verification or exclusion of CRK has to await sequencing of this promising candidate locus in the affected individuals.
In addition to lipoproteins, an increasing number of ligands have been reported for the LDLR-related proteins and essential signal transduction and modulator functions in embryonic development, synaptic transmission, and in the maintenance of vascular integrity are now becoming apparent. 16 Dysequilibrium syndrome secondary to mutations in VLDLR represents the first human lipoprotein receptor malformation syndrome. More recently, mutations in LRP2 (megalin) have been identified in patients with Donnai-Barrow syndrome, which is characterized by agenesis of the corpus callosum, congenital diaphragmatic hernia, facial dysmorphism, ocular anomalies, sensorineural hearing loss, and developmental delay. 26 Mutations in Lrp4 are responsible for a form of polysyndactyly in mice, 27 and syndactyly in cattle. 28, 29 It is likely that additional malformation syndromes caused by mutations in other members of the LDLR family will be identified in the future.
In summary, we report the first patient born to nonconsanguineous parents with 2 deleterious VLDLR mutations and review the reported cases to date. Dysequilibrium syndrome resulting from VLDLR deficiency is a distinct and recognizable syndrome characterized by nonprogressive congenital ataxia, moderate-to-profound mental retardation, occasional seizures, and inferior cerebellar hypoplasia with mild simplification of cortical gyri. We propose that VLDLR deficiency in dysequilibrium syndrome be referred to as VLDLR-associated cerebellar hypoplasia. 
